Increasing knowledge & understanding of aspirin
Founded in 1974, the International Aspirin Foundation shares information and stimulates research interest and discussion about all aspects of aspirin and acetylsalicylic acid.
Menu
Dr Manel Mendoza winner of 2023 Science Award – hear about StopPRE
Scientific Advisory Board
Key Features
Scientific Conference
Dr Mendoza, principal investigator of the StopPRE trial. Watch the presentation about the first trial to investigate the appropriate duration of aspirin treatment to prevent preeclampsia during pregnancy, a major public health problem.
For further details see our Aspirin Summaries section.
Certificate of Advanced Studies in Antithrombotic Management. This unique Post Graduate Course will train you to become a future expert in Anticoagulation Management. The new course will take place: November 9-12, 2023 (first part) and April 11-14, 2024 (second part).
Reflecting on the 125th anniversary of the synthesis of acetylsalicylic acid Professor Peter Elwood, Honorary Professor at the University of Cardiff’s Institute of Primary Care & Public Health, looking ahead to what the future might hold for aspirin. Well known epidemiologist whose landmark research on aspirin in 1974 was of such significance that in 1990 the British Medical Journal declared it one of the top 50 most important research studies published since the 1945.
More recently, Peter Elwood was lead author of a systematic review that showed cancer patients who take aspirin on top of their standard treatment are 20% less likely to die from the disease, and that low-dose aspirin taken regularly also reduces the spread of cancer by a similar margin.
Contributions from the research community shared here are unsolicited and are not peer reviewed. We encourage sharing information and stimulating research interest, but we do not endorse or approve the submission. See full disclaimer
Mervyn Vergouwen, MD PhD,
Professor Mazzeffi.
Sign up to be part of the aspirin community and be the first to receive latest information.
Have something to say about aspirin?
Have something to say about aspirin?
Please fill in the form below and we will contact you with further information.
Have something to say about aspirin?
We would like to hear from you and have a chat, and maybe feature you on our podcast. Please fill in the form below and we will contact you with further information.
Pierre Amarenco, MD, FAHA, FAAN
Neurology and Vascular Neurology
N/A
Adjunct Associate Professor DUKE-NUS Graduate Medical School,
Consultant Oncologist Curie Oncology Singapore,
Visiting Consultant National Cancer Centre Singapore.
Medical Oncology
In the past 3 years, I have received consultant fees from Tessa Therapeutics, Aslan Pharmaceuticals, Novartis, and AstraZeneca.
I received grant support for investigator-initiated research from:
I hold shares in: Roche, BMS, AstraZeneca, Incyte, Teva Pharmaceuticals, Trillium Therapeutics, Compugen, Arrowhead pharmaceuticals, Emergex, QuantumDx and Halozyme Therapeutics
I received consultant and speakers fees from Amgen, AstraZeneca, Bayer, Lilly and Sanofi.
Junbo Ge
Ge Junbo, male, was born in Wulian, Shandong province on Nov. 8, 1962. He is the member of Chinese Academy of Sciences, professor and doctoral supervisor. He received his doctor’s degree of Medicine from German Mayence University in 1993 and now works as the director for Shanghai Institute of Cardiovascular Disease and the Center for Stem Cells and Tissue Engineering, Fudan University. He is also the designate chairman of the Cardiovascular Disease Branch of Chinese Medical Association, council member of the Cardiovascular Angiography and Interventions Association, international consultant of the American Heart Association. In Dec. 2013, he was appointed as the vice president of Tongji University.
Prof. Ge has been engaged in clinical and scientific research work of cardiovascular disease since 1987, and his research area covers the pathogenesis of coronary heart disease, early diagnosis and treatment plan optimization.
AACR Honors Dr. Andrew T. Chan With 2019 AACR-Waun Ki Hong Award
Click here to find the press release.
I received consultant Bayer and Pfizer, Inc.
I received grant support for investigator-initiated research from:
Professor of Medicine, Harvard Medical School; Chief Division of Aging, Brigham and Women’s Hospital; Director of Preventive Cardiology and Director of Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System.
Discipline: Cardiology and Epidemiology
I received consultant and speaker fees Bayer.
I received grant support as a principal investigator or co-investigator for research from the VA, DOD, NIH, Merck and Kowa.
Peter M. Rothwell PhD, MD, FRCP, FMedSci
I received consultant and speakers fees from Acticor Biotech, Amgen, Bayer, GlaxoSmithKline, Tremeau, Zambon.
I received grant support for investigator-initiated research from: